… tamoxifen for disseminated breast cancer in 1971. Following pharmacologic and clinical
evaluation of tamoxifen … for the treatment of metastatic breast cancer in postmenopausal women. …

… mammary carcinogenesis, clinical use of tamoxifen in breast cancer treatment targeting the
… of tamoxifen resistance. A better understanding of the mechanisms for tamoxifen resistance …

… Our site uses cookies to improve your experience. You can find out more about our use of
cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. …

… or tamoxifen, which are the preferred treatments. Because of the rarity of the disease, no large
trials of adjuvant tamoxifen or chemotherapy in men with breast cancer … Its use is therefore …

… Our results suggest that use of HRT increases risk of breast cancer, as could be expected in
… , and that tamoxifen use in women using HRT seems to reduce risk of breast cancer to that …

… tamoxifen use and other risk factors for endometrial cancer … women with endometrial cancer
after breast cancer (cases), … use of tamoxifen as a preventive agent against breast cancer in …

… the prevalence of tamoxifen use by US women for chemoprevention was exceptionally
low. In the year after tamoxifen was approved for chemoprevention of breast cancer, less than …

… have yet been observed in the entire cohort and a much longer follow-up will be needed to
quantify the impact of tamoxifen use on breast-cancer mortality and other long-term risks and …

… of use for most women. We collected information on breast cancer therapies as well as the
use … tamoxifen use and subsequent endometrial cancer risk is substantially modified by ERT …

… At present, our findings support the use and benefits of tamoxifen in breast cancer
patients of all body types, subject to appropriate cautions for the health conditions that often …